Frontiers in Immunology

Original Research

Accepted on 14 Apr 2025

Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation

in Vaccines and Molecular Therapeutics

Dorit Fabricius
Carolin Ludwig
Matthias Proffen
Janina Hägele
Judith Scholz
Christiane Vieweg
Immanuel Rode
Simone Hoffmann
Sixten Körper
Hubert Schrezenmeier

Frontiers in Immunology

doi 10.3389/fimmu.2025.1580448

225 views

Original Research

Accepted on 14 Apr 2025

Evidence of focusing the MHC class I immunopeptidome by tapasin

in Antigen Presenting Cell Biology

Rachel Darley
Patricia T Illing
Patrick Duriez
Alistair Bailey
Anthony Wayne Purcell
Andy van Hateren
Tim Elliott

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563789

Original Research

Accepted on 14 Apr 2025

Th2 predominance and decreased NK cells in patients with hereditary angioedema

in Immunological Tolerance and Regulation

Linda Sundler Björkman
Evelina Elmér
Arne Egesten
Lillemor Skattum

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536128

Original Research

Accepted on 14 Apr 2025

TRIM28 mediates Mettl5 ubiquitination to promotes Th2 polarization

in Immunological Tolerance and Regulation

Pingchang Yang
Beiping Miao
Lihua Mo
Shihan Miao
Xiwen Zhang
Haoyue Zheng
Yixuan Dong
Bailing Xie
Yuanyi Zhang
Yun Liao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524633

Original Research

Accepted on 14 Apr 2025

Two major human phenotypes of MICA molecules and their differential activation to NK cells via NKG2D receptor

in Alloimmunity and Transplantation

Qizhi Luo
Xiangli Yin
Quan Zhu
Weiguang Luo
Rongjiao Liu
Leiyan Wei
Yizhou Zou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563872

Review

Accepted on 14 Apr 2025

Mechanism of Action and Therapeutic Value of Anoctamin-1 in Gastrointestinal Cancers

in Cancer Immunity and Immunotherapy

Xiaoyue Zhang
Jie Lin
Hongpan Xu
Yan Zhou
Zhiyi Mu
Ruizhe Shi
Yalei Lv

Frontiers in Immunology

doi 10.3389/fimmu.2025.1599100

Original Research

Accepted on 14 Apr 2025

Virus-specific host responses and gene signatures following infection with major SARS-CoV-2 Variants of Concern: Role of ZBP1 in viral clearance and lung inflammation

in Viral Immunology

Amany Elsharkawy
Hamid Reza Jahantigh
Anchala Guglani
Shannon Stone
Komal Arora
Mukesh Kumar

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557535

Original Research

Accepted on 14 Apr 2025

IFI27 as a Potential Biomarker and Therapeutic Target in Cervical Cancer: Implications for Anoikis Response

in Cancer Immunity and Immunotherapy

Xiaxia Man
Xue He
Dongzhen Liu
Baogang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1582573

Review

Accepted on 14 Apr 2025

Intraepithelial Lymphocytes in Human Oral Diseases

in Mucosal Immunity

Dong-Yang Zhou
Chao-Fan Bao
Gang Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1597088

Correction

Accepted on 14 Apr 2025

Corrigendum: Infection of a β-galactosidase-deficient mouse strain with Theiler's murine encephalomyelitis virus reveals limited immunological dysregulations in this lysosomal storage disease

in Immunological Tolerance and Regulation

Rouven Wannemacher
Felix Stegmann
Deborah Eikelberg
Melanie Bühler
Dandan Li
Sayali Kalidas Kohale
Thanaporn Asawapattanakul
Tim Ebbecke
Maire-Kristin Raulf
Wolfgang Baumgärtner

Frontiers in Immunology

doi 10.3389/fimmu.2025.1610299

Original Research

Accepted on 14 Apr 2025

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Yufei Lu
Gaofeng Ding
Wen Wang
Qingke Duan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563737

Review

Accepted on 14 Apr 2025

Unveiling Drug Resistance Pathways in High-Grade Serous Ovarian Cancer(HGSOC): Recent Advances and Future Perspectives

in Cancer Immunity and Immunotherapy

Ruiting Fu
Ruiyue Hu
Wenting Li
Xifang Lv
Hanwei Zhao
Fuxia Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1556377

129 views

Review

Accepted on 14 Apr 2025

Immunomodulatory role of RNA modifications in sex hormone-dependent cancers

in Cancer Immunity and Immunotherapy

Yujia Jiang
Xiaolan Liang
Hongyi Sun
Ping Yin
Jing Zhou
Chaoqin Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1513037

Correction

Accepted on 14 Apr 2025

Corrigendum: Characterization of intrahepatic B cells in acute-onchronic liver failure

in Inflammation

Yudong Zhao
Wei He
Chenchen Wang
Nana Cui
Changjie Yang
Zhengrui You
Bisheng Shi
Lei Xia
Xiaosong Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1581969

Review

Accepted on 14 Apr 2025

The Dual Roles of Human PYHIN Family Proteins in Cancer: Mechanisms and Therapeutic Implications

in Cancer Immunity and Immunotherapy

Shuyan Zeng
Zhiyong Zhou
Yi Li
Di Wu
Qiuyun Xiao
Huiyun Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1576674

Case Report

Accepted on 14 Apr 2025

Case Report: Bispecific CD20/CD30-targeted Chimeric Antigen Receptor T-cell Therapy for Non-Hodgkin's Lymphoma

in Cancer Immunity and Immunotherapy

Yuejiao Huang
Yiming Gong
Xiang Liu
Huaying Ruan
Jinhua Lu
Hosein Kouros- Mehr
Hong Liu
Han Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1567149